Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.

In recent years, Kessler has lost considerable weight himself with the help of the new GLP-1 drugs. He describes his weight ...

Shop till you drop: Could Trump upend, reset the age of the insatiable American consumer?

Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

And since GLP-1s come with side effects including fatigue, digestive difficulties, and loss of muscle, products to address ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...

GLP-1s are the main reason why pharmacy expenditures have reached double digits in 2025, a continuing trend from 2024, ...